{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:01:50Z","timestamp":1773270110028,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2321-B-182-001"],"award-info":[{"award-number":["NSTC 114-2321-B-182-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2320-B-255-004-MY3"],"award-info":[{"award-number":["114-2320-B-255-004-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2321-B-255-001"],"award-info":[{"award-number":["114-2321-B-255-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["BMRP450"],"award-info":[{"award-number":["BMRP450"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPF3Q0011\\u223C3"],"award-info":[{"award-number":["CMRPF3Q0011\\u223C3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","award":["ZRRPF3Q0091"],"award-info":[{"award-number":["ZRRPF3Q0091"]}],"id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118261","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:39:04Z","timestamp":1760398744000},"page":"118261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency"],"prefix":"10.1016","volume":"302","author":[{"given":"Reham","family":"Waheed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Emad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Purgatorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Valeria","family":"Miniero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"El Kerdawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Catto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf H.","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsong-Long","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-4219","authenticated-orcid":false,"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118261_bib1","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1074\/jbc.274.23.16162","article-title":"Comparison of the peroxidase reaction kinetics of prostaglandin H Synthase-1 and -2","volume":"274","author":"Lu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118261_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000369826","article-title":"Selective Cyclooxygenase-1 inhibition by P6 and gastrotoxicity: preliminary investigation","volume":"95","author":"Perrone","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2025.118261_bib4","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.ejmech.2025.118261_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fnins.2020.00693","article-title":"Integrated pathways of COX-2 and mTOR: roles in cell sensing and Alzheimer's disease","volume":"14","author":"Tyagi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2025.118261_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68","author":"Morita","year":"2002","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.ejmech.2025.118261_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2025.118261_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.118261_bib11","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2025.118261_bib12","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer' s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejmech.2025.118261_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/138161208784480171","article-title":"Cyclooxygenase-1 and-2 in the different stages of Alzheimer's disease pathology","volume":"14","author":"Hoozemans","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.118261_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-5728(00)00231-9","article-title":"Glia-T cell dialogue","volume":"107","author":"Aloisi","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejmech.2025.118261_bib15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1046\/j.1460-9568.2003.02879.x","article-title":"Expression and localization of cyclooxygenase\u20101 and\u20102 in human sporadic amyotrophic lateral sclerosis","volume":"18","author":"Maih\u00f6fner","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-004-0826-2","article-title":"Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia","volume":"107","author":"Yokota","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2025.118261_bib17","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118261_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: inos, lipocortin-1, and cyclooxygenases-1 and-2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<392::AID-GLIA10>3.0.CO;2-C","article-title":"Cyclooxygenase\u20102 is highly expressed in microglial\u2010like cells in a murine model of prion disease","volume":"29","author":"Walsh","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2025.118261_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-8993(99)01389-X","article-title":"Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs","volume":"830","author":"Yasojima","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2025.118261_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0197-4580(96)00110-8","article-title":"Prostaglandin G\/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease","volume":"17","author":"Chang","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2025.118261_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0306-4522(98)00218-8","article-title":"Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain","volume":"87","author":"Pasinetti","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib23","first-page":"307","article-title":"Regional neuronal loss in aging and Alzheimer's disease: a brief review","volume":"6","author":"O'Banion","year":"1994"},{"key":"10.1016\/j.ejmech.2025.118261_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2025.118261_bib25","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118261_bib26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.8.10.1521","article-title":"COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration","volume":"8","author":"O'Banion","year":"1999","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2025.118261_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118261_bib28","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/ijerph16142560","article-title":"The role of eicosanoids in Alzheimer's disease","volume":"16","author":"Biringer","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ejmech.2025.118261_bib29","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4103\/1673-5374.193234","article-title":"Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics","volume":"11","author":"Metaxas","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2025.118261_bib30","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.118261_bib31","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/acscentsci.1c00585","article-title":"A structural ensemble of a tau-microtubule complex reveals regulatory tau phosphorylation and acetylation mechanisms","volume":"7","author":"Brotzakis","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2025.118261_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118261_bib33","doi-asserted-by":"crossref","first-page":"99296","DOI":"10.18632\/oncotarget.21853","article-title":"COX-2 metabolic products, the prostaglandin I2 and F2\u03b1, mediate the effects of TNF-\u03b1 and Zn2+ in stimulating the phosphorylation of Tau","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118261_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fj.201800355RRRR","article-title":"Integrated communications between cyclooxygenase\u20102 and Alzheimer's disease","volume":"33","author":"Guan","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118261_bib35","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target \u03b3-secretase and lower A\u03b242 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118261_bib38","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.3390\/molecules26113208","article-title":"Progress in PET imaging of neuroinflammation targeting COX-2 enzyme","volume":"26","author":"Prabhakaran","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118261_bib39","first-page":"81s","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.118261_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbi.2012.08.008","article-title":"The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6","volume":"200","author":"Niranjan","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118261_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.mp.4001773","article-title":"Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease","volume":"11","author":"Qin","year":"2006","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.118261_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101729","article-title":"Exploring the role of COX-2 in Alzheimer's disease: potential therapeutic implications of COX-2 inhibitors","volume":"31","author":"Moussa","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejmech.2025.118261_bib43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-190507","article-title":"Developing effective Alzheimer's disease therapies: clinical experience and future directions","volume":"71","author":"Elmaleh","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2025.118261_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222505","article-title":"Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality","volume":"14","author":"Benito-Le\u00f3n","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118261_bib45","doi-asserted-by":"crossref","first-page":"16607","DOI":"10.1039\/c4ra00749b","article-title":"Highly efficient synthesis of azos catalyzed by the common metal copper (0) through oxidative coupling reactions","volume":"4","author":"Wang","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118261_bib46","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1039\/C8TB01796D","article-title":"Nitrogen-doped carbon nanodots for bioimaging and delivery of paclitaxel","volume":"6","author":"Gomez","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2025.118261_bib47","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1002\/anie.201001651","article-title":"Copper\u2010catalyzed aerobic oxidative dehydrogenative coupling of anilines leading to aromatic azo compounds using dioxygen as an oxidant","volume":"49","author":"Zhang","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118261_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1081\/SCC-120030694","article-title":"Reductive cleavage of azo compounds by zinc and ammonium chloride","volume":"34","author":"Sridhara","year":"2004","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.118261_bib49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/B978-0-08-052349-1.00231-6","article-title":"Reduction of Nitro and nitroso","volume":"8","author":"Kabalka","year":"1991","journal-title":"Comp. Org. Synth."},{"key":"10.1016\/j.ejmech.2025.118261_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103759","article-title":"Synthesis of novel 1, 2-diarylpyrazolidin-3-one\u2013based compounds and their evaluation as broad spectrum antibacterial agents","volume":"99","author":"Mokbel","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib51","series-title":"Organic Chemistry: 100 must-know Mechanisms","author":"Valiulin","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118261_bib52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200059060-00001","article-title":"COX-2 selective nonsteroidal anti-inflammatory drugs: do they really offer any advantages?","volume":"59","author":"Jackson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.118261_bib53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","article-title":"COX-2 inhibitors and cardiovascular risk","volume":"50","author":"Funk","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118261_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500096","article-title":"Discovery of safe COX\u20102 inhibitors: achieving reduced colitis side effects through balanced COX inhibition","volume":"20","author":"Zhu","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118261_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.53388\/MDM202508008","article-title":"RCSB Protein Data Bank: revolutionising drug discovery and design for over five decades","volume":"8","author":"Ahmad","year":"2025","journal-title":"Med. Data Min"},{"key":"10.1016\/j.ejmech.2025.118261_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112066","article-title":"Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2\/5-LOX inhibitors","volume":"189","author":"Gedawy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105253","article-title":"Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity","volume":"115","author":"Halim","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2017.06.045","article-title":"Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6)","volume":"138","author":"Cingolani","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib59","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118261_bib60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/jm00219a007","article-title":"A model for the prostaglandin synthetase cyclooxygenation site and its inhibition by antiinflammatory arylacetic acids","volume":"20","author":"Gund","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib61","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118261_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)30822-0","article-title":"Identification of the biologically active form of sulindac","volume":"201","author":"Duggan","year":"1977","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.118261_bib63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118261_bib64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.118261_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35011103","article-title":"Structural insights into the stereochemistry of the cyclooxygenase reaction","volume":"405","author":"Kiefer","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118261_bib66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1367-5931(98)80124-5","article-title":"Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents","volume":"2","author":"Marnett","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118261_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.0909765106","article-title":"Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1","volume":"107","author":"Rimon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118261_bib68","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/bi010045s","article-title":"Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations","volume":"40","author":"Selinsky","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118261_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jsb.2014.11.005","article-title":"The structure of ibuprofen bound to cyclooxygenase-2","volume":"189","author":"Orlando","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.118261_bib70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1182\/blood.V80.3.718.718","article-title":"Rapid ultrastructural changes in the dense tubular system following platelet activation","volume":"80","author":"Ebbeling","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.118261_bib71","first-page":"283","article-title":"Localization of platelet prostaglandin production in the platelet dense tubular system","volume":"83","author":"Gerrard","year":"1976","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2025.118261_bib72","first-page":"253","article-title":"Endocrine regulation of phospholipase as a therapeutic target for cardiovascular diseases","volume":"7","author":"Rajendran","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118261_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2025.118261_bib74","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1074\/jbc.271.4.2179","article-title":"Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1","volume":"271","author":"Bhattacharyya","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib75","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118261_bib76","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/00912700022008766","article-title":"Effects of celecoxib, a novel cyclooxygenase\u20102 inhibitor, on platelet function in healthy adults: a randomized, controlled trial","volume":"40","author":"Leese","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118261_bib77","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118261_bib78","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.3390\/ijms24119647","article-title":"Pro-and anti-inflammatory prostaglandins and cytokines in humans: a mini review","volume":"24","author":"Wautier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118261_bib79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.118261_bib80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u05f3 s disease","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118261_bib81","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1021\/acschemneuro.4c00353","article-title":"Disruption of PHF6 peptide aggregation from Tau protein: mechanisms of palmatine chloride in preventing early PHF6 aggregation","volume":"15","author":"Fagnen","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib82","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ange.201508968","article-title":"Microtubule\u2010binding R3 fragment from tau self\u2010assembles into giant multistranded amyloid ribbons","volume":"128","author":"Adamcik","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118261_bib83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/cn3001922","article-title":"Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein","volume":"4","author":"Dolghih","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1160\/TH03-02-0103","article-title":"The role of PAR4 in thrombin-induced thromboxane production in human platelets","volume":"90","author":"Wu","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejmech.2025.118261_bib85","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/mol.106.023986","article-title":"Prevention of platelet glycoprotein IIb\/IIIa activation by 3, 4-methylenedioxy-\u03b2-nitrostyrene, a novel tyrosine kinase inhibitor","volume":"70","author":"Wang","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118261_bib86","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3390\/molecules24234298","article-title":"A prospective repurposing of dantrolene as a multitarget agent for Alzheimer's disease","volume":"24","author":"Bolognino","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118261_bib87","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/acschemneuro.0c00624","article-title":"Multitarget biological profiling of new naphthoquinone and anthraquinone-based derivatives for the treatment of Alzheimer's disease","volume":"12","author":"Campora","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118261_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116266","article-title":"Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity","volume":"269","author":"Al-Saad","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118261_bib89","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejmech.2016.09.037","article-title":"New azepino [4, 3-b] indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity","volume":"125","author":"De Candia","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:42:15Z","timestamp":1773214935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":89,"alternative-id":["S0223523425010268"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118261","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting COX-2 inhibitors for Alzheimer's disease as multitargeted ligands: Development of 4-hydrazono-pyrazolidinediones with tuned COX selectivity profile and improved cellular potency","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118261"}}